Back to Results
First PageMeta Content
Cardiology / Lipoproteins / Lactones / Statins / Nutrition / Low-density lipoprotein / Simvastatin / Cholesterol / High-density lipoprotein / Medicine / Chemistry / Health


ORIGINAL INVESTIGATION Cost-effectiveness of 3-Hydroxy-3-Methylglutaryl– Coenzyme A Reductase Inhibitors in the Secondary Prevention of Cardiovascular Disease Forecasting the Incremental Benefits of Preventing Coronar
Add to Reading List

Document Date: 2006-10-29 18:01:43

Open Document

File Size: 184,70 KB

Share Result on Facebook

City

Wolf / Montreal / Ottawa / Pointe Claire / Washington / DC / Toronto / /

Company

Grover SA / Goldman / HP / IMS of Canada Ltd. / /

Country

Sweden / United States / Canada / /

Currency

USD / CAD / /

Facility

Blood Institute / ARCH INTERN MED/ VOL / Montreal General Hospital / The Montreal General Hospital / Laboratory Operations / Hospital Statistics / Royal Victoria Hospital / University of North Carolina / Garrison RJ / Chapel Hill / Quebec hospital / Canadian Institute / McGill University / estimated using the Canadian Institute / /

IndustryTerm

stroke prevention / therapy for cerebrovascular disorders / health care services / prevention of coronary artery disease / Prevention of Cardiovascular Disease / physician services / risk factor management / healthcare professionals / mean retail prices / healthcare resources / laboratory services / prevention of coronary heart disease / /

MedicalCondition

glucose intolerance / strokes / JE / dyslipoproteinemias / artery disease / cerebrovascular disease / transient ischemic attack / nonfatal myocardial infarction / coronary heart disease / MS / Coronary Disease / transient ischemic attacks / acute myocardial infarction / arrhythmia / congestive heart failure / peripheral vascular disease / CHD / et al. Heart Disease / predicted stroke / cerebrovascular disorders / stroke / cardiovascular disease / hyperlipidemia / certain cardiovascular disease / definite coronary artery disease / Statin Therapy Among Persons With Cardiovascular Disease / model forecasting stroke / myocardial infarction / both hyperlipidemia and cardiac events / fatal stroke / recurrent myocardial infarction / diabetes mellitus / coronary artery disease / ARDIOVASCULAR disease / myocardial ischemia / acute ischemic stroke / /

MedicalTreatment

angioplasty / cardiac catheterization / statin therapy / coronary artery catheterization / bypass / catheterization / drug therapies / drug therapy / /

NaturalFeature

Chapel Hill / /

OperatingSystem

XP / /

Organization

Royal Victoria Hospital / National Institute of Health / Dept of Health / University of North Carolina / Division of Clinical Epidemiology / Centre for the Analysis / Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks / McGill University / National Heart / Lung / and Blood Institute / Health Statistics Division / Montreal General Hospital / Coordinating Center for the Lipid Research Clinics / Statistics Canada / National Accounts and Environment Division / American Medical Association / American Heart Association / Heart and Stroke Foundation of Canada / Stroke Council / Ministry of Health / Canadian Institute for Health Information / Epidemiology Committee / /

Person

Steven A. Grover / Arch Intern / Nancy Mayo / Louis Coupal / Hanna Zowall / Arch Intern Med / /

Position

physician / General / Corresponding author / Kannel WB / Economic Observer / Fisher / representative / /

Product

Simvastatin / ticlopidine hydrochloride / lovastatin / /

ProvinceOrState

Quebec / Maryland / Michigan / North Carolina / Ontario / /

RadioStation

Garber AM / /

Technology

diagnostic tests / CVD / /

SocialTag